• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why U.S. Stocks Are Trading Lower; AZZ Earnings And More

    7/11/22 10:55:43 AM ET
    $AZZ
    $DOCN
    $FSLY
    $LJPC
    Industrial Specialties
    Industrials
    Computer Software: Programming Data Processing
    Technology
    Get the next $AZZ alert in real time by email

    U.S. stocks traded lower this morning as investors digested the recent jobs report for the month of June.

    The Dow traded down 0.38% to 31,220.54 while the NASDAQ fell 1.67% to 11,441.36. The S&P also fell, dropping, 0.93% to 3,862.94.

    Also check this: GameStop, Levi Strauss And 3 Stocks To Watch Heading Into Friday


    Leading and Lagging Sectors


    Health care shares slipped by just 0.1% on Monday. Meanwhile, top gainers in the sector included Pliant Therapeutics, Inc. (NASDAQ:PLRX), up 117% and Nyxoah S.A. (NASDAQ:NYXH) up 14%.


    In trading on Friday, communication services shares dipped by 2%.


    Top Headline


    AZZ Inc (NYSE:AZZ) reported better-than-expected earnings for its first quarter on Monday.

    AZZ reported first-quarter FY23 sales growth of 36.8% year-over-year to $314.4 million, beating the consensus of $268.09 million. Adjusted EPS jumped 59.1% Y/Y to $1.40, beating the consensus of $1.03.


    Equities Trading UP


    Pliant Therapeutics, Inc. (NASDAQ:PLRX) shares shot up 117% to $19.25 after the company said its treatment for Idiopathic Pulmonary Fibrosis was well tolerated in a Phase 2a study.


    Shares of La Jolla Pharmaceutical Company (NASDAQ:LJPC) got a boost, shooting 81% to $6.14 after Innoviva entered into a definitive agreement to acquire the company for $5.95 per share and an incremental $0.28 per share for additional cash proceeds, or an implied enterprise value of approximately $149 million.


    ToughBuilt Industries, Inc. (NASDAQ:TBLT) shares were also up, gaining 23% to $2.4750 after the company announced its Q2 gross sales through Amazon were $3.56 million, representing a 20% year-over-year increase.


    Equities Trading DOWN

    Fastly, Inc. (NYSE:FSLY) shares tumbled 14% to $11.60 after Morgan Stanley downgraded the stock from Equal-Weight to Underweight and lowered its price target from $18 to $12.


    Shares of Lyell Immunopharma, Inc. (NASDAQ:LYEL) were down 14% to $5.81.


    DigitalOcean Holdings, Inc. (NYSE:DOCN) was down, falling 13% to $40.41 after analysts at Morgan Stanley downgraded their rating of the stock from Equal-Weight to Underweight.


    Also check out: This Low-Float Stock Jumps Around 148%; Here's 64 Biggest Movers From Yesterday


    Commodities

    In commodity news, oil traded down 1.7% to $102.98, while gold traded down 0.3% to $1,737.70.


    Silver traded down 0.5% to $19.15 on Monday while copper fell 3% to $3.4155.



    Euro zone


    European shares were lower today. The eurozone’s STOXX 600 fell 0.6%, London’s FTSE 100 fell 0.2% while Spain’s IBEX 35 Index fell 0.5%. The German DAX declined 1.3%, French CAC 40 fell 0.7% and Italy’s FTSE MIB Index fell 0.7%.

    Italy’s industrial production fell 1.1% from a month ago in May versus a revised 1.4% growth in the April. France recorded a current account deficit of EUR 3.9 billion in May versus a revised EUR 2.7 billion gap in the prior month, while trade deficit increased to EUR 13 billion in May from a revised EUR 12.7 billion in the previous month.


    Economics


    The Treasury is set to auction 3-and 6-month bills at 11:30 a.m. ET.


    The Treasury will also auction 3-year notes at 1:00 p.m. ET.


    Federal Reserve Bank of New York President John Williams will speak at 2:00 p.m. ET.

    Check out this: U.S. Jobs Growth Might Slow To This Level In June, Here's The Major Macro Issues For Friday


    COVID-19 Update

    The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 90,065,160 cases with around 1,045,080 deaths. India confirmed a total of at least 43,587,300 cases and 525,340 deaths, while Brazil reported over 32,761,040 COVID-19 cases with 673,120 deaths. In total, there were at least 558,810,440 cases of COVID-19 worldwide with more than 6,369,440 deaths.

    Get the next $AZZ alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AZZ
    $DOCN
    $FSLY
    $LJPC

    CompanyDatePrice TargetRatingAnalyst
    Fastly Inc.
    $FSLY
    2/12/2026Mkt Perform → Outperform
    William Blair
    DigitalOcean Holdings Inc.
    $DOCN
    2/5/2026$68.00Neutral → Overweight
    Cantor Fitzgerald
    Lyell Immunopharma Inc.
    $LYEL
    12/9/2025$45.00Neutral → Buy
    H.C. Wainwright
    Fastly Inc.
    $FSLY
    11/17/2025Perform
    Oppenheimer
    DigitalOcean Holdings Inc.
    $DOCN
    11/10/2025$60.00Outperform
    Oppenheimer
    DigitalOcean Holdings Inc.
    $DOCN
    11/6/2025$60.00Underperform → Buy
    BofA Securities
    Pliant Therapeutics Inc.
    $PLRX
    10/10/2025Neutral → Underweight
    Analyst
    DigitalOcean Holdings Inc.
    $DOCN
    10/7/2025$40.00Neutral
    UBS
    More analyst ratings

    $AZZ
    $DOCN
    $FSLY
    $LJPC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Fastly upgraded by William Blair

    William Blair upgraded Fastly from Mkt Perform to Outperform

    2/12/26 7:17:35 AM ET
    $FSLY
    Computer Software: Prepackaged Software
    Technology

    DigitalOcean upgraded by Cantor Fitzgerald with a new price target

    Cantor Fitzgerald upgraded DigitalOcean from Neutral to Overweight and set a new price target of $68.00

    2/5/26 6:50:53 AM ET
    $DOCN
    Computer Software: Programming Data Processing
    Technology

    Lyell Immunopharma upgraded by H.C. Wainwright with a new price target

    H.C. Wainwright upgraded Lyell Immunopharma from Neutral to Buy and set a new price target of $45.00

    12/9/25 8:34:46 AM ET
    $LYEL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AZZ
    $DOCN
    $FSLY
    $LJPC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Seely Lynn sold $174,372 worth of shares (7,455 units at $23.39), decreasing direct ownership by 9% to 74,266 units (SEC Form 4)

    4 - Lyell Immunopharma, Inc. (0001806952) (Issuer)

    2/12/26 8:47:49 PM ET
    $LYEL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Operating Officer Hill Stephen J. sold $28,910 worth of shares (1,236 units at $23.39), decreasing direct ownership by 6% to 17,795 units (SEC Form 4)

    4 - Lyell Immunopharma, Inc. (0001806952) (Issuer)

    2/12/26 8:46:32 PM ET
    $LYEL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Scientific Officer Lee Gary K. sold $39,085 worth of shares (1,671 units at $23.39), decreasing direct ownership by 9% to 16,938 units (SEC Form 4)

    4 - Lyell Immunopharma, Inc. (0001806952) (Issuer)

    2/12/26 8:44:57 PM ET
    $LYEL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AZZ
    $DOCN
    $FSLY
    $LJPC
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Fastly Inc.

    SCHEDULE 13G/A - Fastly, Inc. (0001517413) (Subject)

    2/12/26 4:05:08 PM ET
    $FSLY
    Computer Software: Prepackaged Software
    Technology

    Fastly Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Fastly, Inc. (0001517413) (Filer)

    2/11/26 4:06:04 PM ET
    $FSLY
    Computer Software: Prepackaged Software
    Technology

    SEC Form SCHEDULE 13G filed by Fastly Inc.

    SCHEDULE 13G - Fastly, Inc. (0001517413) (Subject)

    2/11/26 12:49:30 PM ET
    $FSLY
    Computer Software: Prepackaged Software
    Technology

    $AZZ
    $DOCN
    $FSLY
    $LJPC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Lyell Immunopharma Announces Initiation of Patient Dosing in First-of-Its-Kind Phase 3 Head-To-Head CAR T-Cell Clinical Trial in Aggressive Large B-Cell Lymphoma

    PiNACLE – H2H will evaluate the efficacy and safety of rondecabtagene autoleucel (ronde-cel) versus Investigator's choice of approved CD19 CAR T-cell therapies in patients with aggressive large B-cell lymphoma receiving treatment in the second-line settingThe pivotal single-arm trial, PiNACLE, evaluating ronde-cel in the third- or later-line setting is ongoing with BLA submission expected in 2027Site activation for both PiNACLE – H2H and PiNACLE are underway in the United States, Canada and Australia SOUTH SAN FRANCISCO, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (NASDAQ:LYEL), a clinical-stage company advancing a pipeline of next-generation chimeric antigen recept

    2/12/26 7:30:00 AM ET
    $LYEL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Fastly Announces Both Record Fourth Quarter and Full Year 2025 Financial Results

    Record fourth quarter revenue of $172.6 million grew 23% year over year Record fourth quarter gross margin of 61.4% and record non-GAAP gross margin of 64.0% Record RPO of $353.8 million grew 55% year over year Fastly, Inc. (NASDAQ:FSLY), a leading global edge cloud platform, today announced financial results for its fourth quarter and full year ended December 31, 2025. "Our fourth quarter results mark an inflection in Fastly's growth as we achieved record revenue, gross margin, and operating profit," said Kip Compton, CEO of Fastly. "In 2025 we made significant progress on Fastly's transformation and delivered great results. As we look toward 2026, we anticipate continued momentum,

    2/11/26 4:05:00 PM ET
    $FSLY
    Computer Software: Prepackaged Software
    Technology

    DigitalOcean Announces Date of Fourth Quarter 2025 Earnings Conference Call

    DigitalOcean Holdings, Inc. (NYSE:DOCN), the agentic inference cloud, announced today that it will report financial results for the fourth quarter and full year ended December 31, 2025 and host an extended investor update before the market opens on Tuesday, February 24, 2026. Following the earnings release, DigitalOcean will host an extended virtual earnings results and investor update featuring presentations from Paddy Srinivasan, Chief Executive Officer, and Matt Steinfort, Chief Financial Officer. In addition to the standard earnings update, the event will provide additional context on the company's strategic priorities, product strategy and long-term growth outlook. DigitalOcean's e

    2/9/26 4:05:00 PM ET
    $DOCN
    Computer Software: Programming Data Processing
    Technology

    $AZZ
    $DOCN
    $FSLY
    $LJPC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Brawley Otis W bought $19,958 worth of shares (35,640 units at $0.56) (SEC Form 4)

    4 - Lyell Immunopharma, Inc. (0001806952) (Issuer)

    4/2/25 3:46:01 PM ET
    $LYEL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Ramachandra Sumant bought $115,220 worth of shares (200,000 units at $0.58) (SEC Form 4)

    4 - Lyell Immunopharma, Inc. (0001806952) (Issuer)

    3/25/25 6:46:17 PM ET
    $LYEL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Klausner Richard bought $94,942 worth of shares (158,000 units at $0.60) (SEC Form 4)

    4 - Lyell Immunopharma, Inc. (0001806952) (Issuer)

    3/18/25 8:07:51 PM ET
    $LYEL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AZZ
    $DOCN
    $FSLY
    $LJPC
    Leadership Updates

    Live Leadership Updates

    View All

    DigitalOcean Appoints Vinay Kumar as Chief Product and Technology Officer

    DigitalOcean (NYSE:DOCN) today announced the appointment of Vinay Kumar as Chief Product and Technology Officer (CPTO). In this role, Vinay will lead product strategy, product development, cloud infrastructure, and security, with responsibility for defining and executing DigitalOcean's platform roadmap as the company scales its AI inference cloud and core cloud offerings. Vinay brings more than a decade of senior leadership experience building, operating, and scaling large-scale cloud platforms and mission-critical infrastructure. He was one of the founding members of Oracle Cloud Infrastructure (OCI), where he helped build and scale OCI from inception into a global hyperscale cloud platf

    1/20/26 8:05:00 AM ET
    $DOCN
    Computer Software: Programming Data Processing
    Technology

    Astro Shapes Announces Appointment of Carol Jackson as Chief Executive Officer

    Astro Shapes, a leading manufacturer of custom aluminum extrusions, and a portfolio company of Wynnchurch Capital, L.P. ("Wynnchurch"), today announced the appointment of Carol Jackson as Chief Executive Officer. Ms. Jackson brings extensive executive experience and a proven track record of driving growth and operational excellence. She previously served as President, Chairman, and CEO of HarbisonWalker International (HWI), now part of Calderys. Prior to joining HWI in 2014, she was Vice President of the bar, wire, and strip business units at Carpenter Technology Corporation (NYSE:CRS). Earlier in her career, she spent over 12 years at PPG Industries (NYSE:PPG), where she held numerous lea

    12/2/25 10:05:00 AM ET
    $AZZ
    $CRS
    $PPG
    Industrial Specialties
    Industrials
    Steel/Iron Ore
    Paints/Coatings

    Fastly Announces Listing Transfer to Nasdaq

    Ticker symbol to remain "FSLY" Fastly, Inc. (NYSE:FSLY), a leader in global edge cloud platforms, announced today that it will voluntarily transfer its stock exchange listing from the New York Stock Exchange ("NYSE") to the Nasdaq Global Select Market ("Nasdaq"). Fastly expects to begin trading as a Nasdaq-listed company on or about December 9, 2025, and will continue to trade under its current ticker symbol "FSLY". "We're excited to join Nasdaq and be listed among the most innovative and leading technology companies in the world," said Kip Compton, CEO at Fastly. "This is one of several steps in our current transformation as we scale Fastly while working to unlock long-term value for cus

    11/26/25 8:00:00 AM ET
    $FSLY
    Computer Software: Prepackaged Software
    Technology

    $AZZ
    $DOCN
    $FSLY
    $LJPC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Pliant Therapeutics Inc.

    SC 13G - PLIANT THERAPEUTICS, INC. (0001746473) (Subject)

    11/14/24 9:00:58 PM ET
    $PLRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by ToughBuilt Industries Inc.

    SC 13G/A - Toughbuilt Industries, Inc (0001668370) (Subject)

    11/14/24 7:29:15 PM ET
    $TBLT
    Industrial Machinery/Components
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Pliant Therapeutics Inc.

    SC 13G/A - PLIANT THERAPEUTICS, INC. (0001746473) (Subject)

    11/14/24 5:05:23 PM ET
    $PLRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AZZ
    $DOCN
    $FSLY
    $LJPC
    Financials

    Live finance-specific insights

    View All

    Fastly Announces Both Record Fourth Quarter and Full Year 2025 Financial Results

    Record fourth quarter revenue of $172.6 million grew 23% year over year Record fourth quarter gross margin of 61.4% and record non-GAAP gross margin of 64.0% Record RPO of $353.8 million grew 55% year over year Fastly, Inc. (NASDAQ:FSLY), a leading global edge cloud platform, today announced financial results for its fourth quarter and full year ended December 31, 2025. "Our fourth quarter results mark an inflection in Fastly's growth as we achieved record revenue, gross margin, and operating profit," said Kip Compton, CEO of Fastly. "In 2025 we made significant progress on Fastly's transformation and delivered great results. As we look toward 2026, we anticipate continued momentum,

    2/11/26 4:05:00 PM ET
    $FSLY
    Computer Software: Prepackaged Software
    Technology

    DigitalOcean Announces Date of Fourth Quarter 2025 Earnings Conference Call

    DigitalOcean Holdings, Inc. (NYSE:DOCN), the agentic inference cloud, announced today that it will report financial results for the fourth quarter and full year ended December 31, 2025 and host an extended investor update before the market opens on Tuesday, February 24, 2026. Following the earnings release, DigitalOcean will host an extended virtual earnings results and investor update featuring presentations from Paddy Srinivasan, Chief Executive Officer, and Matt Steinfort, Chief Financial Officer. In addition to the standard earnings update, the event will provide additional context on the company's strategic priorities, product strategy and long-term growth outlook. DigitalOcean's e

    2/9/26 4:05:00 PM ET
    $DOCN
    Computer Software: Programming Data Processing
    Technology

    AZZ Inc. Issues Fiscal Year 2027 Guidance

    FORT WORTH, Texas, Feb. 4, 2026 /PRNewswire/ -- AZZ Inc. (NYSE:AZZ), the leading independent provider of hot-dip galvanizing and coil coating solutions, today announced financial guidance for fiscal year 2027. Fiscal year 2027 refers to the 12-month period beginning on March 1, 2026, and ending on February 28, 2027. FY2026 Guidance FY2027 Guidance (1) Sales $1.625 - $1.725 billion $1.725 - $1.775 billion Adjusted EBITDA $360 - $380 million $360 - $400 million Adjusted Diluted EPS $5.90 - $6.20 $6.50 - $7.00 (1) FY2027 Guidance Assumptions: a. The newly built Washington, Missou

    2/4/26 4:15:00 PM ET
    $AZZ
    Industrial Specialties
    Industrials